<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00515359</url>
  </required_header>
  <id_info>
    <org_study_id>2007-140</org_study_id>
    <nct_id>NCT00515359</nct_id>
  </id_info>
  <brief_title>RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies</brief_title>
  <official_title>RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spectrum Health Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Helen DeVos Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Spectrum Health Hospitals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RCT for Intermittent versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI&#xD;
      Studies&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A study comparing the dose of propofol used as a continuous infusion versus intermittent&#xD;
      bolus dosing looking at recovery time complications, and quality of the MRI studies in&#xD;
      Pediatric Sedation Services for patients age 1 month to 18 years receiving an brain or spine&#xD;
      MRI.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">February 2009</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>to compare recovery time, complications and quality of the MRI studies when continuous infusion of propofol was used versus intermittent bolus dosing</measure>
    <time_frame>study completion</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Encephalopathy</condition>
  <condition>Developmental Delay and Behavioral Changes</condition>
  <condition>Cord Tumor Compression or Instability</condition>
  <condition>Cord Tethering or Malformation</condition>
  <arm_group>
    <arm_group_label>Dose Comparison</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>continuous versus intermittent bolus dosing</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intermittent Propofol Sedation</intervention_name>
    <description>Intermittent versus continuous dosage</description>
    <arm_group_label>Dose Comparison</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous Propofol Sedation</intervention_name>
    <description>intermittent vs continuous dosage</description>
    <arm_group_label>Dose Comparison</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 1 month to 18 years&#xD;
&#xD;
          -  Receiving a brain or spine MRI with propofol sedation&#xD;
&#xD;
          -  Deemed safe to undergo sedation with propofol based on a pre-sedation examination&#xD;
&#xD;
          -  Patient judged not to require any pre-medication with any other medication except&#xD;
             nasal decongestants or anticholinergic medications&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient below or above set age limits.&#xD;
&#xD;
          -  Patient requires MRI studies on other body areas.&#xD;
&#xD;
          -  Patient requires pre-medication with a sedative or tranquilizer&#xD;
&#xD;
          -  Patient requires additional medications during sedation to complete the procedure.&#xD;
&#xD;
          -  Propofol is being used as a rescue sedative to complete the procedure.&#xD;
&#xD;
          -  Propofol is being used as a rescue sedative to complete a procedure that was initiated&#xD;
             by another sedative.&#xD;
&#xD;
          -  Patients who develop complications that require termination of the imaging procedure&#xD;
             will not be included in the dose or recovery time calculations, but the complication&#xD;
             will be counted as such in their respective group and study will be reported as&#xD;
             non-diagnostic.&#xD;
&#xD;
          -  Insulin dependent diabetes&#xD;
&#xD;
          -  Thyroid disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nabil Hassan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helen DeVos Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Spectrum Health</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2009</verification_date>
  <study_first_submitted>August 7, 2007</study_first_submitted>
  <study_first_submitted_qc>August 10, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2007</study_first_posted>
  <last_update_submitted>January 26, 2010</last_update_submitted>
  <last_update_submitted_qc>January 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2010</last_update_posted>
  <responsible_party>
    <name_title>Nabil Hassan, MD</name_title>
    <organization>Helen DeVos Children's Hospital</organization>
  </responsible_party>
  <keyword>Sedation</keyword>
  <keyword>MRI</keyword>
  <keyword>pediatric</keyword>
  <keyword>propofol</keyword>
  <keyword>brain</keyword>
  <keyword>spine</keyword>
  <keyword>quality of MRI</keyword>
  <keyword>Continuous propofol dosing</keyword>
  <keyword>continuous propofol administration</keyword>
  <keyword>Intermittent propofol dosing</keyword>
  <keyword>intermittent propofol administration</keyword>
  <keyword>Sedative agent</keyword>
  <keyword>propofol continuous infusions</keyword>
  <keyword>Recovery time</keyword>
  <keyword>Complications of sedation</keyword>
  <keyword>bolus dosing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Problem Behavior</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

